Table 1.
Developmental risk factors |
Innate immune effects(s) |
Altered inflammatory conditions |
References |
---|---|---|---|
Maternal smoking and ETS |
Altered expression of TLRs; increased numbers of lung mast cells and eosinophils; decreased phago- cytosis but ele- vated production of ROS by macrophages |
Dyslipidemia, hyper- inflammation; higher infant oxi- dative stress |
Blacquiere et al. (2009) Ishida et al. (2009) Ng et al. (2009) Noakes et al. (2006, 2007) Pfefferle, Pinkenburg, and Renz (2010) Yu et al. (2009) |
Air and/or traffic pollution |
Variant TLR-2 and 4 alleles affect pol- lutant impact |
Increased eosinophil- lic inflammation and airway remodeling |
Clark et al. (2010) Herr et al. (2010, 2011) Kerkhof et al. (2010) Morgenstern et al. (2008) |
Ozone | Disrupted epithelial barrier; altered macrophage function |
Interaction with maternal PM exposure to pro- duce childhood airway hyperreactivity |
Auten et al. (2009)
Hollingsworth, Kleeberger, and Foster (2007) Lin et al. (2008) |
Pb and synergistic effects with other metals |
Altered dendritic cell maturation (pro- motion of Th2); excessive TNF- alpha and ROS by macrophages |
Inflammatory dys- function; promo- tion of tissue damage, apoptosis and DNA mutagenesis |
Bishayi and Sengupta (2006)
Kasten-Jolly, Heo, and Lawrence (2010) Snyder et al. (2000) |
Polychlorinated biphenyls |
Macrophage apopto- sis; disrupted epi- thelial barrier function |
Upregulation of ICAM-1, MCP-1; Notch3, CCLs and IL-8; enhanced vascular adhesion and inflammation |
Choi et al. (2010)
Eum et al. (2009) Felty, Yoo, and Kennedy (2010) Grandjean et al. (2010) Majkova et al. (2009) Shin et al. (2000 |
Maternal and early childhood paracetamol use |
Decreased gluthathione, TNF-alpha and IL-6 production by pulmonary macrophages |
Glutathione deple- tion; increased oxidant-induced inflammation |
Bakkeheim et al. (2010)
Beasley et al. (2008) Dimova et al. (2005) Etminan et al. (2009) Farquhar et al. (2010) Gonzalez-Diaz et al. (2010) Shaheen, Newson, Ring, et al. (2010) |